PL395231A1 - Sposób zmniejszania nadmiernego pocenia się skóry - Google Patents

Sposób zmniejszania nadmiernego pocenia się skóry

Info

Publication number
PL395231A1
PL395231A1 PL395231A PL39523103A PL395231A1 PL 395231 A1 PL395231 A1 PL 395231A1 PL 395231 A PL395231 A PL 395231A PL 39523103 A PL39523103 A PL 39523103A PL 395231 A1 PL395231 A1 PL 395231A1
Authority
PL
Poland
Prior art keywords
skin
way
excessive sweating
reducing excessive
reducing
Prior art date
Application number
PL395231A
Other languages
English (en)
Inventor
Michelle Zheng Lu
Robert E. Kalafsky
Michele C. Duggan
Original Assignee
Avon Products, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avon Products, Inc. filed Critical Avon Products, Inc.
Publication of PL395231A1 publication Critical patent/PL395231A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70—Biological properties of the composition as a whole

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PL395231A 2002-12-31 2003-12-17 Sposób zmniejszania nadmiernego pocenia się skóry PL395231A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/334,887 US6866856B2 (en) 2002-12-31 2002-12-31 Compositions and delivery methods for the treatment of wrinkles, fine lines and hyperhidrosis

Publications (1)

Publication Number Publication Date
PL395231A1 true PL395231A1 (pl) 2011-09-12

Family

ID=32655203

Family Applications (2)

Application Number Title Priority Date Filing Date
PL395231A PL395231A1 (pl) 2002-12-31 2003-12-17 Sposób zmniejszania nadmiernego pocenia się skóry
PL377443A PL377443A1 (pl) 2002-12-31 2003-12-17 Kompozycja do leczenia zmarszczek, drobnych zmarszczek i nadmiernego pocenia się oraz sposób jej zastosowania

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL377443A PL377443A1 (pl) 2002-12-31 2003-12-17 Kompozycja do leczenia zmarszczek, drobnych zmarszczek i nadmiernego pocenia się oraz sposób jej zastosowania

Country Status (9)

Country Link
US (1) US6866856B2 (pl)
EP (1) EP1471874A4 (pl)
JP (1) JP2006514657A (pl)
AU (1) AU2003303628B2 (pl)
BR (1) BR0307124A (pl)
CA (1) CA2470201C (pl)
MX (1) MXPA04006896A (pl)
PL (2) PL395231A1 (pl)
WO (1) WO2004060326A1 (pl)

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040220100A1 (en) * 2000-07-21 2004-11-04 Essentia Biosystems, Inc. Multi-component biological transport systems
JP5610659B2 (ja) * 2000-07-21 2014-10-22 ルバンス セラピュティックス インク．Ｒｅｖａｎｃｅ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． 多成分生物学的輸送システム
US6916120B2 (en) * 2002-01-30 2005-07-12 Adc Telecommunications, Inc. Fiber optic connector and method
US20040131565A1 (en) * 2002-10-29 2004-07-08 Lee Letica Lipstick composition containing essential oils
US7477940B2 (en) 2003-06-30 2009-01-13 J&J Consumer Companies, Inc. Methods of administering an active agent to a human barrier membrane with galvanic generated electricity
US7477941B2 (en) * 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of exfoliating the skin with electricity
US7476222B2 (en) 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of reducing the appearance of pigmentation with galvanic generated electricity
US8734421B2 (en) * 2003-06-30 2014-05-27 Johnson & Johnson Consumer Companies, Inc. Methods of treating pores on the skin with electricity
US7486989B2 (en) 2003-06-30 2009-02-03 Johnson & Johnson Consumer Companies, Inc. Device for delivery of oxidizing agents to barrier membranes
US7480530B2 (en) * 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Device for treatment of barrier membranes
US7477938B2 (en) 2003-06-30 2009-01-13 Johnson & Johnson Cosumer Companies, Inc. Device for delivery of active agents to barrier membranes
US7507228B2 (en) 2003-06-30 2009-03-24 Johnson & Johnson Consumer Companies, Inc. Device containing a light emitting diode for treatment of barrier membranes
US7479133B2 (en) * 2003-06-30 2009-01-20 Johnson & Johnson Consumer Companies, Inc. Methods of treating acne and rosacea with galvanic generated electricity
US7477939B2 (en) 2003-06-30 2009-01-13 Johnson & Johnson Consumer Companies, Inc. Methods of treating a wound with galvanic generated electricity
JP2007527431A (ja) * 2004-03-03 2007-09-27 ルバンス セラピュティックス 局所的診断及び治療用の輸送のための組成物及び方法
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
BRPI0508410B8 (pt) * 2004-03-03 2021-05-25 Revance Therapeutics Inc composições e métodos para a aplicação tópica e liberação transdérmica de toxinas botulínicas
US20060135383A1 (en) * 2004-12-17 2006-06-22 Cossa Anthony J Cleansing compositions comprising polymeric emulsifiers and methods of using same
EP1827111A4 (en) * 2004-12-22 2015-07-22 Avon Prod Inc METHOD AND COMPOSITION FOR REDUCING FOLDING PERFORMANCE
MX2007010674A (es) * 2005-03-03 2007-11-08 Revance Therapeutics Inc Composiciones y metodos para la aplicacion topica y el suministro transdermico de un oligopeptido.
ZA200707352B (en) 2005-03-03 2009-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
ES2259928B1 (es) 2005-04-08 2007-11-01 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales.
US20070065515A1 (en) * 2005-09-22 2007-03-22 Key Douglas J Methods and compositions for treating skin lines and wrinkles and improving skin quality
CN103126971A (zh) * 2005-11-17 2013-06-05 雷文斯治疗公司 减少非毒素蛋白质的肉毒杆菌毒素组合物和其局部施用及透皮递送方法
US7544375B1 (en) 2006-06-12 2009-06-09 Swiss Skin Repair, Inc. Composition
WO2008032331A1 (en) * 2006-09-12 2008-03-20 Himalaya Global Holdings Ltd. Herbal composition for the prevention of wrinkles and skin disorders, methods of preparing the same and uses thereof
BRPI0720729A2 (pt) * 2006-12-29 2014-04-08 Revance Therapeutics Inc Moléculas de transporte que utilizam polipeptídeos hiv-tat de sequência inversa.
CN102988995A (zh) * 2006-12-29 2013-03-27 雷文斯治疗公司 用源自hiv-tat的多肽片段稳定的肉毒杆菌毒素的组合物及其局部施用和透皮递送的方法
EP2749552B1 (en) * 2007-04-17 2015-11-18 Codman & Shurtleff, Inc. Curcumin-resveratrol hybrids
US8383865B2 (en) * 2007-04-17 2013-02-26 Codman & Shurtleff, Inc. Curcumin derivatives
EP2659896A3 (en) * 2007-09-28 2014-06-11 Johnson & Johnson Consumer Companies Inc. Electricity-generating particulates and the use thereof
US7745670B2 (en) * 2008-06-27 2010-06-29 Codman & Shurtleff, Inc. Curcumin-Resveratrol hybrid molecule
US7985776B2 (en) 2008-06-27 2011-07-26 Codman & Shurtleff, Inc. Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease
US20100082088A1 (en) * 2008-08-27 2010-04-01 Ali Fassih Treatment of sweating and hyperhydrosis
US8150525B2 (en) * 2008-08-27 2012-04-03 Johnson & Johnson Consumer Companies, Inc. Treatment of hyperhydrosis
EP2330910B1 (en) * 2008-09-11 2017-08-16 Israeli Biotechnology Research Ltd. Cosmetic use of leucojum bulb extracts
US7723515B1 (en) * 2009-01-26 2010-05-25 Codman & Shurtleff, Inc. Methylene blue—curcumin analog for the treatment of alzheimer's disease
US20100286585A1 (en) * 2009-01-26 2010-11-11 Codman & Shurtleff, Inc. Shunt Delivery of Curcumin
US20120089232A1 (en) 2009-03-27 2012-04-12 Jennifer Hagyoung Kang Choi Medical devices with galvanic particulates
KR101226660B1 (ko) 2009-06-19 2013-01-25 일동제약주식회사 투센다닌 또는 멀구슬나무 추출물을 유효성분으로 함유하는 치매 예방 또는 치료용 조성물
JP5616045B2 (ja) * 2009-10-05 2014-10-29 花王株式会社 セラミド産生促進剤及び保湿剤
JP5689247B2 (ja) * 2010-04-28 2015-03-25 花王株式会社 セラミド産生促進剤及び保湿剤
WO2011043212A1 (ja) * 2009-10-05 2011-04-14 花王株式会社 セラミド産生促進剤及び保湿剤
US8744567B2 (en) * 2009-11-13 2014-06-03 Johnson & Johnson Consumer Companies, Inc. Galvanic skin treatment device
JP2011105666A (ja) * 2009-11-19 2011-06-02 Kao Corp ドーパオキシダーゼ活性抑制剤及び美白剤
US8747383B2 (en) * 2009-12-18 2014-06-10 University Medical Pharmaceuticals Corp. Process and system for iontophoretic wrinkle reduction
KR20110091461A (ko) * 2010-02-05 2011-08-11 존슨 앤드 존슨 컨수머 캄파니즈, 인코포레이티드 갈바니 미립자를 포함하는 립 조성물
EP2542209A1 (en) * 2010-03-01 2013-01-09 Johnson & Johnson Consumer Companies, Inc. Skin care composition having desirable bulk color
US20110236491A1 (en) * 2010-03-25 2011-09-29 Jeannette Chantalat Topical anti-inflammatory composition
JP2012167022A (ja) * 2011-02-09 2012-09-06 Kao Corp セラミド産生促進剤、保湿剤及び皮膚外用剤
JP2012167023A (ja) * 2011-02-09 2012-09-06 Kao Corp セラミド産生促進剤、保湿剤及び皮膚外用剤
WO2013070808A1 (en) 2011-11-07 2013-05-16 Feng Tian Peptide-based compounds as inhibitors of neurotransmitter secretion
KR101723084B1 (ko) * 2014-06-23 2017-04-04 대한민국 노밀린 또는 이의 약학적으로 허용 가능한 염을 포함하는 주름 개선 또는 피부 탄력 증진용 화장료 조성물
US20190015467A1 (en) * 2017-07-12 2019-01-17 Kao Corporation Agent for preventing or ameliorating uneven skin tone
ES3060502T3 (en) 2018-06-13 2026-03-26 Acraf Peptides having inhibitory activity on neuronal exocytosis
NL2035921B1 (en) * 2023-05-05 2025-01-27 Coty Inc Cosmetic composition
CN118557456A (zh) * 2024-08-01 2024-08-30 广东冠清柠生物科技有限公司 含柠檬苦素的抗炎组合物、抗炎化妆品制剂和制备方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5228854B2 (pl) * 1974-06-27 1977-07-29
CH624011A5 (pl) 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4379454A (en) 1981-02-17 1983-04-12 Alza Corporation Dosage for coadministering drug and percutaneous absorption enhancer
US4708861A (en) 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US4820724A (en) 1986-03-31 1989-04-11 University Of Southern California Dual phase solvent carrier system
US5223262A (en) 1989-02-23 1993-06-29 University Of Utah Transdermal delivery system utilizing one way membranes
US4956171A (en) 1989-07-21 1990-09-11 Paco Pharmaceutical Services, Inc. Transdermal drug delivery using a dual permeation enhancer and method of performing the same
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5376363A (en) 1991-05-03 1994-12-27 Bristol-Myers Squibb Company Clear gelled antiperspirant stick composition
US5370873A (en) 1992-09-11 1994-12-06 Udeinya; Iroka J. Therapeutic compounds derived from the neem tree
AU690069B2 (en) * 1993-02-09 1998-04-23 Tulsa Forte Pharmacy Enterprises, Inc. A method for stimulating hair growth with cationic derivatives of minoxidil using therapeutic iontophoresis
USH1541H (en) 1993-07-21 1996-06-04 Holla; Kadambar S. Method for producing azadirachtin concentrates from neem seed materials
JP3541049B2 (ja) * 1993-11-12 2004-07-07 御木本製薬株式会社 ヒアルロニダーゼ阻害剤
US6974578B1 (en) * 1993-12-28 2005-12-13 Allergan, Inc. Method for treating secretions and glands using botulinum toxin
US5500209A (en) 1994-03-17 1996-03-19 The Mennen Company Deodorant and antiperspirant compositions containing polyamide gelling agent
FR2747308B1 (fr) * 1996-04-11 1998-07-10 Shrivastava Ravi Association de margousier, de (-) hydroxycitrate et de ceramides et compositions les renfermant
US5932229A (en) 1996-04-25 1999-08-03 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
US5834513A (en) 1996-04-25 1998-11-10 Avon Products, Inc. Oxa diacids and related compounds for treating skin conditions
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
US5998423A (en) 1996-10-08 1999-12-07 Therasys, Inc. Methods for modulating melanin production
US6338855B1 (en) 1996-10-25 2002-01-15 The Procter & Gamble Company Cleansing articles for skin and/or hair which also deposit skin care actives
US5885600A (en) 1997-04-01 1999-03-23 Burlington Bio-Medical & Scientific Corp. Natural insect repellent formula and method of making same
DE69808790T3 (de) 1997-09-12 2009-07-16 The Procter & Gamble Co., Cincinnati Hautreinigungs- und konditionierungsartikel für haut und haar
US6239114B1 (en) * 1997-09-26 2001-05-29 Kgk Synergize Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
US6251400B1 (en) * 1997-09-26 2001-06-26 Kgk Synergize Inc Compositions and methods of treatment of neoplastic diseases and hypercholesterolemia with citrus limonoids and flavonoids and tocotrienols
AU1231000A (en) 1998-10-26 2000-05-15 University Of Massachusetts Treatment of skin with adenosine or adenosine analog
DE19852981A1 (de) * 1998-11-17 2000-05-18 Martin Schmidt Botulinum-Toxine, deren Derivate, Analoge und molekulare Bruchstücke zur topischen epicutanen Anwendung auch in Zusammenwirken mit hautpenetrationsfördernden Substanzen und Maßnahmen in Zubereitungsformen zur Beeinflussung acetylcholinabhängiger Körperfunktionen
FR2787996B1 (fr) * 1998-12-30 2002-05-10 Dior Christian Parfums Composition cosmetique ou dermatologique contenant un actif stimulant la synthese de la proteine hsp 32 dans la peau et methode de traitement cosmetique
FR2793681B1 (fr) * 1999-05-18 2001-06-22 Oreal Utilisation d'au moins un inhibiteur d'au moins un canal calcique dans le traitement des rides
WO2001012206A2 (de) * 1999-08-13 2001-02-22 Heinrich Wieland Soja-glycine extracten und aromatase-hemendern zur positiven beeinflussung von kollagen
CN1306750A (zh) 2000-01-28 2001-08-08 武长安 草本植物杀虫剂
US6753315B2 (en) 2000-02-24 2004-06-22 Brown University Research Foundation α-bungarotoxin molecules and uses thereof
IT1318425B1 (it) * 2000-03-24 2003-08-25 D B P Dev Biotechnological Pro Impiego del resveratrolo per il trattamento di eczema desquamativo,acne e psoriasi.
DE10021560A1 (de) * 2000-05-03 2001-11-08 Promelia Produkte Mit Naturext Hautpflegemittel mit insektenrepellierender Wirkung
JP2001316239A (ja) * 2000-05-10 2001-11-13 Mikimoto Pharmaceut Co Ltd 皮膚外用剤
JP3928153B2 (ja) * 2001-01-19 2007-06-13 コスメディ製薬株式会社 シート状貼付剤
US20030091665A1 (en) * 2001-11-09 2003-05-15 Avon Products, Inc Topical cosmetic composition with skin rejuvenation benefits
US20030124205A1 (en) * 2001-12-28 2003-07-03 Avon Products, Inc. Topical cosmetic composition having a natural plant active ingredient and method of using same

Also Published As

Publication number Publication date
AU2003303628A1 (en) 2004-07-29
AU2003303628B2 (en) 2006-03-09
PL377443A1 (pl) 2006-02-06
WO2004060326A1 (en) 2004-07-22
CA2470201C (en) 2006-09-26
MXPA04006896A (es) 2004-12-06
EP1471874A4 (en) 2007-06-27
EP1471874A1 (en) 2004-11-03
JP2006514657A (ja) 2006-05-11
US20040127556A1 (en) 2004-07-01
CA2470201A1 (en) 2004-06-30
US6866856B2 (en) 2005-03-15
BR0307124A (pt) 2004-12-07

Similar Documents

Publication Publication Date Title
PL395231A1 (pl) Sposób zmniejszania nadmiernego pocenia się skóry
DE60324099D1 (de) Arzneistoffhaltiger tampon
DE03764480T1 (de) Flexibler kanülenstiel
DE60333495D1 (de) Wund- und hautpflegezusammensetzungen
DE60221143D1 (de) Brusteinlage enthaltend hautpflegemittel
ATE370714T1 (de) Geformtes tampon
PL376715A1 (pl) Kompozycja terapeutyczna do skóry do stosowania miejscowego
EP1530449A4 (en) Artificial cornea
DE60336213D1 (de) Chirurgisches klammergerät
EP1583493A4 (en) Wound dressing
DE60304102D1 (de) Hautreinigungszusammensetzung
DE60313805D1 (de) Steuerbarer Katheter
EP1477118A4 (en) ULTRASOUND DEVICE
EP1500371A4 (en) ULTRASOUND DEVICE
ATE358836T1 (de) Umreifungsband
DE60311298D1 (de) Kopfhautbehandlung
IS2421B (is) Nýir etónógestrel esterar
DE60335019D1 (de) Topische hautpräparate
EP1500370A4 (en) Ultrasonograph
FR2837366B3 (fr) Unite cosmetique
NO20050689L (no) Terapeutisk anvendelse
EP1500694A4 (en) LUBRICANT COMPOSITION
DE60222664D1 (de) Hautbehandlungsmittel
DE50307081D1 (de) Gabelbrücke
IS7902A (is) Blettaeyðandi samsetning fyrir húðumhirðu

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)